The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
NCT01378533
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
epirubicin, cyclophosphamide, paclitaxel, carboplatin, G-CSF
Sponsor
Chinese Academy of Medical Sciences